Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia

Upregulation of the immune response may be involved in the pathogenesis of schizophrenia with changes occurring in both peripheral blood and brain tissue. To date, microarray technology has provided a limited view of specific inflammatory transcripts in brain perhaps due to sensitivity issues. Here we used SOLiD Next Generation Sequencing to quantify neuroimmune mRNA expression levels in the dorsolateral prefrontal cortex of 20 individuals with schizophrenia and their matched controls. We detected 798 differentially regulated transcripts present in people with schizophrenia compared with controls. Ingenuity pathway analysis identified the inflammatory response as a key change. Using quantitative real-time PCR we confirmed the changes in candidate cytokines and immune modulators, including interleukin (IL)-6, IL-8, IL-1β and SERPINA3. The density of major histocompatibility complex-II-positive cells morphologically resembling microglia was significantly increased in schizophrenia and correlated with IL-1β expression. A group of individuals, most of whom had schizophrenia, were found to have increased inflammatory mRNA expression. In summary, we have demonstrated changes in an inflammatory response pathway that are present in ∼40% of people diagnosed with schizophrenia. This suggests that therapies aimed at immune system attenuation in schizophrenia may be of direct benefit in the brain.

[1]  Wenzheng Zhang,et al.  Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: Involvement in depression , 2011, Behavioural Brain Research.

[2]  M. Gerstein,et al.  RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.

[3]  Masanori Kato,et al.  Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases , 2000, Brain Research.

[4]  Michal J. Okoniewski,et al.  Hybridization interactions between probesets in short oligo microarrays lead to spurious correlations , 2006, BMC Bioinformatics.

[5]  H. Herken,et al.  Research Paper Mediators of Inflammation, 10, 109–115 (2001) ACTIVAT ION of the inflammatory response system and , 2022 .

[6]  C. Nitsch,et al.  Interleukin-6 receptor expression and localization after transient global ischemia in gerbil hippocampus , 2003, Neuroscience Letters.

[7]  S. Akhondzadeh,et al.  Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial , 2007, Schizophrenia Research.

[8]  M. Oitzl,et al.  Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. , 1993, Brain research.

[9]  Pat Levitt,et al.  Molecular Evidence for Increased Expression of Genes Related to Immune and Chaperone Function in the Prefrontal Cortex in Schizophrenia , 2007, Biological Psychiatry.

[10]  S. Maier,et al.  Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses , 2007, Brain, Behavior, and Immunity.

[11]  C. Heldin,et al.  Interleukin-6 and Neural Stem Cells: More than Gliogenesis to Further Clarify the Specific Role of Il-6 and Its Specific Il-6r on Nscs' Phenotype Change and Differentiation, We , 2008 .

[12]  C. Weickert,et al.  Increased Interstitial White Matter Neuron Density in the Dorsolateral Prefrontal Cortex of People with Schizophrenia , 2011, Biological Psychiatry.

[13]  J. Heroux,et al.  Interleukin-6 mRNA expression by cortical neurons in culture: Evidence for neuronal sources of interleukin-6 production in the brain , 1995, Journal of Neuroimmunology.

[14]  M. Webster,et al.  Changes in alternative brain‐derived neurotrophic factor transcript expression in the developing human prefrontal cortex , 2009, The European journal of neuroscience.

[15]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[16]  C. Stefanis,et al.  Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients , 2001, Schizophrenia Research.

[17]  B. Bogerts,et al.  Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization , 2006, Acta Neuropathologica.

[18]  Yong-Ku Kim,et al.  Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics , 2000, Schizophrenia Research.

[19]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[20]  Selection of Reference Gene Expression in a Schizophrenia Brain Cohort , 2010, The Australian and New Zealand journal of psychiatry.

[21]  F. Holsboer,et al.  Cellular Localization of Interleukin 6 mRNA and Interleukin 6 Receptor mRNA in Rat Brain , 1993, The European journal of neuroscience.

[22]  J. Mege,et al.  Elevated circulating levels of IL-6 in schizophrenia , 1996, Schizophrenia Research.

[23]  M. Behrens,et al.  Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia , 2008, The Journal of Neuroscience.

[24]  F. Aloisi Immune function of microglia , 2001, Glia.

[25]  Sean M. Grimmond,et al.  X-MATE: a flexible system for mapping short read data , 2011, Bioinform..

[26]  Knut Wenzig,et al.  SPSS TwoStep Cluster - a first evaluation , 2004 .

[27]  Shuxian Hu,et al.  Cytokine regulation of human microglial cell IL-8 production. , 1998, Journal of immunology.

[28]  E. Bosmans,et al.  The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. , 1998, Cytokine.

[29]  Kevin L Quick,et al.  Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase , 2007, Science.

[30]  X. Zhang,et al.  Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. , 2004, The Journal of clinical psychiatry.

[31]  R. Pioli,et al.  The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 , 1998, Schizophrenia Research.

[32]  H. Möller,et al.  Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment , 2010, Schizophrenia Research.

[33]  D W Dickson,et al.  Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. , 1993, Journal of immunology.

[34]  Lin He,et al.  Convergent Evidence Shows a Positive Association of Interleukin-1 Gene Complex Locus with Susceptibility to Schizophrenia in the Caucasian population , 2010, Schizophrenia Research.

[35]  D. Lewis,et al.  Neuroplasticity of Neocortical Circuits in Schizophrenia , 2008, Neuropsychopharmacology.

[36]  J. Kleinman,et al.  Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia , 2010, Neuroscience.

[37]  M. Rietschel,et al.  Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia. , 2002, American journal of medical genetics.

[38]  P. Fishman,et al.  Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[39]  Jeffrey K. Yao,et al.  Elevated interleukin-6 in schizophrenia , 1999, Psychiatry Research.

[40]  M. Vallejo,et al.  Regulation of somatostatin gene expression by brain derived neurotrophic factor in fetal rat cerebrocortical cells , 2011, Brain Research.

[41]  Lan Wang,et al.  Global proteomic profiling reveals altered proteomic signature in schizophrenia serum , 2010, Molecular Psychiatry.

[42]  A. Huber,et al.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.

[43]  S. Pääbo,et al.  Transcriptome analysis of male–female differences in prefrontal cortical development , 2009, Molecular Psychiatry.

[44]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Toru,et al.  Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics , 2005, Journal of Neural Transmission.

[46]  Rudi A. Dierckx,et al.  Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study , 2009, Journal of Nuclear Medicine.

[47]  R. Boellaard,et al.  Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study , 2008, Biological Psychiatry.

[48]  A. Sheikh,et al.  IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation , 2011, Journal of Neuroinflammation.

[49]  A. Boyajyan,et al.  Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia. , 2012, Tissue antigens.

[50]  N. Moyna,et al.  Stressor-Induced Alteration of Cytokine Production in Multiple Sclerosis Patients and Controls , 1998, Psychosomatic medicine.

[51]  B. Bogerts,et al.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.

[52]  Alan S. Brown The environment and susceptibility to schizophrenia , 2011, Progress in Neurobiology.

[53]  B. Rabin,et al.  Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness , 1994, Psychiatry Research.

[54]  Peter Ponsaerts,et al.  Microglia: gatekeepers of central nervous system immunology , 2009, Journal of leukocyte biology.

[55]  H. Steinbusch,et al.  Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients , 2009, Neuropsychobiology.

[56]  J. Feldon,et al.  Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia , 2010, Neuropsychopharmacology.

[57]  Johan Kreuger,et al.  Inflammation-related genes up-regulated in schizophrenia brains , 2007 .

[58]  S. Maier,et al.  Sustained hippocampal IL-1β overexpression impairs contextual and spatial memory in transgenic mice , 2010, Brain, Behavior, and Immunity.

[59]  C. Aston,et al.  Microarray analysis of postmortem temporal cortex from patients with schizophrenia , 2004, Journal of neuroscience research.

[60]  Abdel G. Elkahloun,et al.  Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response , 2012, Brain, Behavior, and Immunity.

[61]  R. Kahn,et al.  Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. , 2010, The Journal of clinical psychiatry.

[62]  F. Kapczinski,et al.  Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. , 2011, Revista brasileira de psiquiatria.

[63]  P. Falkai,et al.  Evidence for activation of microglia in patients with psychiatric illnesses , 1999, Neuroscience Letters.

[64]  J. W. Rudy,et al.  Early-life infection leads to altered BDNF and IL-1β mRNA expression in rat hippocampus following learning in adulthood , 2008, Brain, Behavior, and Immunity.

[65]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[66]  A. Carè,et al.  Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. , 1992, Journal of immunology.

[67]  X. Zhang,et al.  Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology , 2002, Schizophrenia Research.

[68]  A. Roberts,et al.  IL-6 Mediated Degeneration of Forebrain GABAergic Interneurons and Cognitive Impairment in Aged Mice through Activation of Neuronal NADPH Oxidase , 2009, PloS one.

[69]  L. Garey,et al.  Increase in HLA‐DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics , 2000, Journal of neuropathology and experimental neurology.

[70]  Rodney W. Johnson,et al.  Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior , 2011, Journal of Neuroinflammation.

[71]  S. Bilbo,et al.  Microglia and Memory: Modulation by Early-Life Infection , 2011, The Journal of Neuroscience.

[72]  U. Otten,et al.  Interleukin‐6 and Interleukin‐6 Receptor mRNA Expression in Rat Central Nervous System a , 1995, Annals of the New York Academy of Sciences.

[73]  Sean M. Grimmond,et al.  The uniqueome: a mappability resource for short-tag sequencing , 2010, Bioinform..

[74]  R. Murray,et al.  Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. , 2011, The Journal of clinical psychiatry.

[75]  M. Barnes,et al.  Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function , 2009, Molecular Psychiatry.

[76]  H. Schiöth,et al.  Memory impairment induced by IL-1β is reversed by α-MSH through central melanocortin-4 receptors , 2009, Brain, Behavior, and Immunity.

[77]  E. Lewandowska,et al.  Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. , 2005, Folia neuropathologica.

[78]  M. Webster,et al.  Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. , 2010, The American journal of psychiatry.

[79]  M. Schwarz,et al.  Immune System and Schizophrenia. , 2010, Current immunology reviews.

[80]  M. Oitzl,et al.  Interleukin-1β, but not interleukin-6, impairs spatial navigation learning , 1993, Brain Research.